Gouranga Saha

Review discussing coordination between ubiquitin–proteasome system (UPS) and kinases in regulating the G1/S cell-cycle transition and implications for cancer biology. Cited by 2.

Peer-reviewed article reporting that PLGA-based dual loading of TMZ and DIM enhances drug delivery across the blood–brain barrier, increases DNA damage and apoptosis, reduces tumor burden and systemic toxicity in preclinical glioma models. Cited by 12.

Preprint describing development of a PLGA-based nanoparticle co-encapsulating Temozolomide and 3,3'-diindolylmethane (DIM) to enhance brain tumor drug delivery and therapeutic synergy in preclinical models. Cited by 6.

Review summarizing USP7's roles across cancer hallmarks and discussing USP7-targeting strategies and inhibitor development challenges. Cited by 89.

Study reporting a helically constrained peptide that inhibits p53-HDM2 interaction and demonstrates synergistic anti-proliferative effects when combined with a USP7 inhibitor. Cited by 2.

Research article identifying XIAP as a USP7 deubiquitination substrate and describing a p53-independent pathway by which USP7 promotes glioma progression; includes in vitro and in vivo combinatorial inhibition results. Cited by 32.

Review of vulnerabilities and therapeutic opportunities in the USP7-p53/MDM2 axis in cancer, discussing USP7-targeting strategies and implications for therapy. Cited by 9.

Encyclopedia chapter summarizing USP7's functions, regulatory mechanisms, and roles in cancer signaling pathways.

Article discussing USP7's dual roles in maintaining cellular homeostasis and promoting tumorigenesis, highlighting context-dependent functions.

Overview of regulatory mechanisms controlling USP7 and its role in oncogenesis.

Book chapter detailing the mechanisms of host-pathogen interactions specifically related to COVID-19, contributing to understanding infection pathways and immune responses.

A book chapter exploring recent advancements in therapeutic approaches to treat COVID-19, covering antiviral drugs, immunomodulators, and vaccine development.